Barclays PLC Mimedx Group, Inc. Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Barclays PLC holds 251,351 shares of MDXG stock, worth $1.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
251,351
Previous 262,449
4.23%
Holding current value
$1.9 Million
Previous $1.55 Million
55.94%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding MDXG
# of Institutions
231Shares Held
101MCall Options Held
34.6KPut Options Held
36.5K-
Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$213 Million62.7% of portfolio
-
Black Rock Inc. New York, NY9.31MShares$70.2 Million0.0% of portfolio
-
Trigran Investments, Inc.7.62MShares$57.5 Million9.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.71MShares$50.6 Million0.0% of portfolio
-
Paradigm Capital Management Inc4.66MShares$35.2 Million1.25% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $857M
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...